6598 — Applied BioCode Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Applied BioCode, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	848	646	831	605	857
Net Total Accounts Receivable
Net Total Receivables	49.5	67.8	70.8	51	45
Total Inventory
Total Other Current Assets
Total Current Assets	1,021	826	1,014	837	1,104
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	172	163	170	131	98.8
Net Intangible Assets
Other Long Term Assets
Total Assets	1,227	1,019	1,212	993	1,215
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	77.8	59.9	87.6	102	130
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	140	116	396	332	336
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	1,087	903	816	661	879
Total Liabilities & Shareholders' Equity	1,227	1,019	1,212	993	1,215
Total Common Shares Outstanding